Intra-Cellular Therapies, Inc. | Business Contracts

Non-Employee Director Compensation Policy, as amended (Filed With SEC on May 4, 2023)

Amendment No. 1 to Master Services Agreement dated as of December 19, 2022 by and between ITI Limited and Lonza Ltd (Filed With SEC on March 1, 2023)

Supply Agreement dated as of January 5, 2023 by and between Siegfried AG and the Registrant (Filed With SEC on March 1, 2023)

License Agreement dated as of May 31, 2005 by and between Bristol-Myers Squibb Company and Intra-Cellular Therapies, Inc (Filed With SEC on August 9, 2022)

Non-Employee Director Compensation Policy, as amended (Filed With SEC on May 10, 2022)

Employment Agreement effective as of September 12, 2018 by and between Suresh Durgam, M.D. and Intra-Cellular Therapies, Inc (Filed With SEC on March 1, 2022)

Employee Proprietary Information, Inventions, Inventions, and Non-Competition Agreement effective as of September 12, 2018 by and between Suresh Durgam, M.D. and Intra-Cellular... (Filed With SEC on March 1, 2022)

Description of securities (Filed With SEC on March 1, 2022)

Underwriting Agreement, dated January 4, 2022, by and among the Company, J.P. Morgan Securities LLC, SVB Leerink LLC, BofA Securities, Inc., Evercore Group L.L.C. and RBC Capital... (Filed With SEC on January 5, 2022)

Supply Agreement dated as of January 4, 2017 by and between Siegfried Evionnaz SA and ITI Limited (Filed With SEC on January 5, 2022)

Amendment to Supply Agreement dated as of December 24, 2021 by and between Siegfried Evionnaz SA and ITI Limited (Filed With SEC on December 29, 2021)

Non-Employee Director Compensation Policy, as amended (Filed With SEC on August 9, 2021)

Employment Agreement effective as of September 12, 2018 by and between Suresh Durgam, M.D. and Intra-Cellular Therapies, Inc (Filed With SEC on February 25, 2021)

Master Services Agreement, effective as of January 10, 2017, by and between ITI Limited and Lonza Ltd (Filed With SEC on November 9, 2020)

Underwriting Agreement, dated September 10, 2020, by and among the Company, J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC, and SVB Leerink LLC, as representatives of the... (Filed With SEC on September 11, 2020)

Form of Director Restricted Stock Unit Agreement under the Amended and Restated 2018 Equity Incentive Plan (Filed With SEC on August 10, 2020)

Form of Restricted Stock Unit Agreement under the Amended and Restated 2018 Equity Incentive Plan (Filed With SEC on August 10, 2020)

Form of Director Stock Option Agreement under the Amended and Restated 2018 Equity Incentive Plan (Filed With SEC on August 10, 2020)

Form of Stock Option Agreement under the Amended and Restated 2018 Equity Incentive Plan (Filed With SEC on August 10, 2020)

Amended and Restated 2018 Equity Incentive Plan (Filed With SEC on May 28, 2020)

Intra-Cellular Therapies, Inc. 2019 Inducement Award Plan (Filed With SEC on March 2, 2020)

Description of securities (Filed With SEC on March 2, 2020)

Form of Stock Option Agreement under the 2019 Inducement Award Plan (Filed With SEC on March 2, 2020)

Form of Restricted Stock Unit Agreement under the 2019 Inducement Award Plan (Filed With SEC on March 2, 2020)

Non-Employee Director Compensation Policy, as amended (Filed With SEC on March 2, 2020)

Underwriting Agreement, dated January 7, 2020, by and among the Company, J.P. Morgan Securities LLC and SVB Leerink LLC, as representatives of the several underwriters named... (Filed With SEC on January 8, 2020)

Employee Proprietary Information, Inventions, Inventions, and Non-Competition Agreement effective as of December 10, 2018 by and between Mark Neumann and Intra-Cellular Therapies,... (Filed With SEC on February 27, 2019)

Employment Agreement effective as of October 15, 2018 by and between Mark Neumann and Intra-Cellular Therapies, Inc (Filed With SEC on February 27, 2019)

Non-Employee Director Compensation Policy, as Amended (Filed With SEC on August 2, 2018)

Intra-Cellular Therapies, Inc. 2018 Equity Incentive Plan (Filed With SEC on June 21, 2018)

Form of Director Restricted Stock Unit Agreement under the 2018 Equity Incentive Plan (Filed With SEC on June 21, 2018)

Form of Director Stock Option Agreement under the 2018 Equity Incentive Plan (Filed With SEC on June 21, 2018)

Form of Stock Option Agreement under the 2018 Equity Incentive Plan (Filed With SEC on June 21, 2018)

Form of Restricted Stock Unit Agreement under the 2018 Equity Incentive Plan (Filed With SEC on June 21, 2018)

Employee Proprietary Information, Inventions, Inventions, and Non-Competition Agreement effective as of November 13, 2017 by and between Andrew Satlin, M.D. and Intra-Cellular... (Filed With SEC on March 1, 2018)

Non-Employee Director Compensation Policy, as amended (Filed With SEC on March 1, 2018)

Employment Agreement effective as of November 13, 2017 by and between Andrew Satlin, M.D. and Intra-Cellular Therapies, Inc (Filed With SEC on March 1, 2018)

Underwriting Agreement, dated September 27, 2017, by and among the Company, J.P. Morgan Securities LLC and Leerink Partners LLC, as representatives of the several underwriters... (Filed With SEC on September 28, 2017)

SUPPLY AGREEMENT (Filed With SEC on March 1, 2017)

AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT (Filed With SEC on November 9, 2016)

INTRA-CELLULAR THERAPIES, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (adopted June 30, 2014; amended March 30, 2016) (Filed With SEC on April 28, 2016)

EMPLOYMENT AGREEMENT (Filed With SEC on February 25, 2016)

INTRA-CELLULAR THERAPIES, INC. EMPLOYEE PROPRIETARY INFORMATION, INVENTIONS, AND NON-COMPETITION AGREEMENT (Filed With SEC on February 25, 2016)

EMPLOYMENT AGREEMENT (Filed With SEC on November 5, 2015)

INTRA-CELLULAR THERAPIES, INC. 7,935,000 Shares of Common Stock (Including 1,035,000 Option Shares) Underwriting Agreement (Filed With SEC on September 23, 2015)

INTRA-CELLULAR THERAPIES, INC. AMENDED AND RESTATED 2013 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:AUGUST 23, 2013 AMENDED BY THE BOARDOF DIRECTORS: APRIL 23, 2015... (Filed With SEC on June 18, 2015)

INTRA-CELLULAR THERAPIES, INC. AT-THE-MARKET OFFERING PROGRAM $50,000,000 SALESAGREEMENT (Filed With SEC on May 28, 2015)

INTRA-CELLULAR THERAPIES, INC. EMPLOYEE PROPRIETARY INFORMATION, INVENTIONS, AND NON-COMPETITION AGREEMENT (Filed With SEC on March 12, 2015)

TERMINATION AGREEMENT (Filed With SEC on March 12, 2015)

INTRA-CELLULAR THERAPIES, INC. 5,462,500 Shares of Common Stock (Including 712,500 Option Shares) Underwriting Agreement (Filed With SEC on March 6, 2015)

3960 Broadway, 6th Floor, NewYork, New York 10032 Phone ###-###-#### Fax ###-###-#### (Filed With SEC on November 3, 2014)

INTRA-CELLULAR THERAPIES, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (adopted June 30, 2014) (Filed With SEC on August 12, 2014)

INTRA-CELLULAR THERAPIES, INC. EMPLOYEE PROPRIETARY INFORMATION, INVENTIONS, AND NON-COMPETITION AGREEMENT (Filed With SEC on March 25, 2014)

INTRA-CELLULAR THERAPIES, INC. 2013 EQUITY INCENTIVE PLAN OPTION GRANT NOTICE (Filed With SEC on March 25, 2014)

INTRA-CELLULAR THERAPIES, INC. Shares of Common Stock Underwriting Agreement (Filed With SEC on January 24, 2014)

LICENSE AGREEMENT between INTRA-CELLULAR THERAPIES, INC. and BRISTOL-MYERS SQUIBB COMPANY (Filed With SEC on October 31, 2013)

LICENSE AND COLLABORATION AGREEMENT (Filed With SEC on October 31, 2013)

INTRA-CELLULAR THERAPIES, INC. EMPLOYEE PROPRIETARY INFORMATION, INVENTIONS, AND NON-COMPETITION AGREEMENT (Filed With SEC on September 5, 2013)

INTRA-CELLULAR THERAPIES, INC. REGISTRATION RIGHTS AGREEMENT (Filed With SEC on September 5, 2013)

INDEMNITY AGREEMENT (Filed With SEC on September 5, 2013)

REDEMPTION AGREEMENT (Filed With SEC on September 5, 2013)

INTRA-CELLULAR THERAPIES, INC. (formerly Oneida Resources Corp.) 2013 EQUITYINCENTIVE PLAN ADOPTED BY THEBOARD OF DIRECTORS: AUGUST 23, 2013 APPROVEDBY THE STOCKHOLDERS: AUGUST... (Filed With SEC on September 5, 2013)

INTRA-CELLULAR THERAPIES, INC. 2003 EQUITY INCENTIVE PLAN STOCK OPTION AGREEMENT (INCENTIVE AND NONSTATUTORY STOCK OPTIONS) (Filed With SEC on September 5, 2013)

INTRA-CELLULAR THERAPIES, INC. 2003 EQUITY INCENTIVE PLAN ADOPTED: JULY 18, 2003 APPROVED BY STOCKHOLDERS: SEPTEMBER 1, 2003 TERMINATION DATE: JULY 17, 2013 (Filed With SEC on September 5, 2013)

INDEMNIFICATION AGREEMENT (Filed With SEC on September 5, 2013)

INTRA-CELLULAR THERAPIES, INC. EMPLOYEE PROPRIETARY INFORMATION, INVENTIONS, AND NON-COMPETITION AGREEMENT (Filed With SEC on September 5, 2013)

AGREEMENT AND PLAN OF MERGER (Filed With SEC on September 5, 2013)

INTRA-CELLULAR THERAPIES, INC. EMPLOYEE PROPRIETARY INFORMATION, INVENTIONS, AND NON-COMPETITION AGREEMENT (Filed With SEC on September 5, 2013)

Intra-Cellular Therapies, Inc. (Filed With SEC on September 5, 2013)

EMPLOYMENT AGREEMENT (Filed With SEC on September 5, 2013)

LICENSE AND COLLABORATION AGREEMENT (Filed With SEC on September 5, 2013)

AMENDMENT NO. 1 TO LICENSE AGREEMENT (Filed With SEC on September 5, 2013)

LICENSE AGREEMENT between INTRA-CELLULAR THERAPIES, INC. and BRISTOL-MYERS SQUIBB COMPANY (Filed With SEC on September 5, 2013)

AMENDMENT OF INTRA-CELLULAR THERAPIES, INC. WARRANT TO PURCHASE COMMONSTOCK (Filed With SEC on September 5, 2013)

INTRA-CELLULAR THERAPIES, INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on September 5, 2013)

Signature(s) Guaranteed: Medallion Guarantee Stamp (Filed With SEC on September 5, 2013)

AGREEMENT AND PLAN OF MERGER by and among Intra-Cellular Therapies, Inc., Oneida Resources Corp. and ITI, Inc. August 23, 2013 TABLE OF CONTENTS (Filed With SEC on August 29, 2013)

Intra-Cellular Therapies, Inc. (85)